1-20 of 302
Richard E Champlin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Follow-up of the Combination of Low-Intensity Chemotherapy Plus Inotuzumab Ozogamicin with or without Blinatumomab in Patients with Relapsed-Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Trial

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Nicholas J. Short, MD, Partow Kebriaei, MD, Xuelin Huang, PhD, Nitin Jain, MD, Marina Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Richard E. Champlin, MD, Tapan M. Kadia, MD, Koichi Takahashi, MD PhD, Naval Daver, MD, Hind Rafei, MD, Joseph D. Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Sa A Wang, MD, Maria R Khouri, Jovitta Jacob, Rebecca Garris, MSc, Susan M. O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–42.
DOI: https://doi.org/10.1182/blood-2020-139896
Published: 2020
Journal Articles

A Prognostic Model for Survival in Patients with Relapsed/Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia on the Combination of Low-Intensity Chemotherapy Plus Inotuzumab Ozogamicin with or without Blinatumomab

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Nicholas J. Short, MD, Partow Kebriaei, MD, Xuelin Huang, PhD, Nitin Jain, MD, Marina Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Richard E. Champlin, MD, Tapan M. Kadia, MD, Koichi Takahashi, MD PhD, Hind Rafei, MD, Sa A Wang, MD, Joseph D. Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Maria Khouri, Jovitta Jacob, Rebecca Garris, MSc, Susan M. O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–4.
DOI: https://doi.org/10.1182/blood-2020-140037
Published: 2020
Journal Articles

Roleof Allogeneic Stem Cell Transplant (ASCT) in Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab (Blina): Results from a Phase 2 Study

Hind Rafei, MD, Hagop M. Kantarjian, MD, Koji Sasaki, MD, Nicholas J. Short, MD, Farhad Ravandi, MBBS, Xuelin Huang, PhD, Joseph D. Khoury, MD, Sa A Wang, MD, Jeffrey L. Jorgensen, MD PhD, Issa F. Khouri, MD, Partow Kebriaei, MD, Richard E. Champlin, MD, Nitin Jain, MD, Bouthaina S. Dabaja, MD, Ghayas C. Issa, MD, Naveen Pemmaraju, MD, Tapan M. Kadia, MD, Shilpa Paul, PharmD, Nadya Jammal, PharmD, Guillermo Garcia-Manero, MD, William G. Wierda, MD PhD, Courtney D. DiNardo, MD MSCE, Naval Daver, MD, Guillermo Montalban-Bravo, MD, Rita Khouri, Patrice Nasnas, MD, Philip A. Thompson, MB, MS, Jovitta Jacob, Meagan Rostykus, RN, Rebecca Garris, MSc, Marina Konopleva, MD PhD, Susan M. O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–41.
DOI: https://doi.org/10.1182/blood-2020-143286
Published: 2020
Journal Articles

African-Americans Multiple-Myeloma Patients Undergoing Upfront Autologous Stem Cell Transplant Have Similar Survival Outcomes Compared to Whites: A Propensity-Score Matched Analysis

Neeraj Saini, MD, Junsheng Ma, MS, Qaiser Bashir, MD, Ruby Delgado, Gabriela Rondon, Uday R. Popat, MD, Chitra Hosing, MD, Yago Nieto, MD, Partow Kebriaei, MD, Amin M. Alousi, MD, Rohtesh S. Mehta, MDMPH,MS, Samer A. Srour, MD MS, Issa F. Khouri, MD, Donna M. Weber, MD, Sheeba K. Thomas, MD, Hans C. Lee, MD, Krina K. Patel, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
DOI: https://doi.org/10.1182/blood-2020-134837
Published: 2020
Journal Articles

Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience

Yago Nieto, MD, Stephen K. Gruschkus, PhD MPH, Roy B. Jones, MD PhD, Benigno C. Valdez, PhD, Melissa Timmons, PA-C, Chitra Hosing, MD, Paolo Anderlini, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Amin M. Alousi, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Jin S. Im, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD PhD, Alison Gulbis, Terri Lynn Shigle, PharmD, Kris Michael Mahadeo, MD, Sajad Khazal, MD, Issa F. Khouri, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Hun Lee, MD, Sairah Ahmed, MD, Raphael Eric Steiner, MD, Swaminathan P Iyer, MD, Ranjit Nair, MD, Simrit Parmar, MD, MSCI, Branko Cuglievan, MD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Borje S. Andersson, MD, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
DOI: https://doi.org/10.1182/blood-2020-139880
Published: 2020
Journal Articles

Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with t(11;14) Undergoing Autologous Hematopoietic Stem Cell Transplantation

Aimaz Afrough, MD, Leonard C Alsfeld, MD, Samer A. Srour, MD MS, Qaiser Bashir, MD, Neeraj Saini, MD, Chitra Hosing, MD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Ruby Delgado, Regan Murphy, PA-C, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
DOI: https://doi.org/10.1182/blood-2020-141307
Published: 2020
Journal Articles

PBSC Mobilization for Auto-HSCT in Myeloma: Growth Factors Vs Growth Factors + Chemotherapy

Jeremy L. Ramdial, MD, Junsheng Ma, MS, Denai R. Milton, MS, Ruby Delgado, Qaiser Bashir, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Yago Nieto, MD, Chitra Hosing, MD, Uday R. Popat, MD, Regan Murphy, PA-C, Hans C. Lee, MD, Krina K. Patel, MD, Elisabet E. Manasanch, MD, Sheeba K. Thomas, MD, Gregory P. Kaufman, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
DOI: https://doi.org/10.1182/blood-2020-143108
Published: 2020
Journal Articles

Comparison of Hyper-CVAD Plus Ofatumumab to Hyper-CVAD Plus Rituximab in Patients with Newly Diagnosed Philadelphia Chromosome-Negative CD20-Positive B-Cell Acute Lymphoblastic Leukemia: A Propensity Score Analysis

Kiyomi Morita, MDPhD, Koji Sasaki, MD, Guillaume Richard-Carpentier, MD, Marina Konopleva, MD PhD, Xuelin Huang, PhD, Nicholas J. Short, MD, Nitin Jain, MD, Farhad Ravandi, MBBS, Bouthaina S. Dabaja, MD, Naval Daver, MD, Tapan M. Kadia, MD, Yesid Alvarado, MD, Courtney D. DiNardo, MD MSCE, Ghayas C. Issa, MD, Naveen Pemmaraju, MD, Guillermo Garcia-Manero, MD, Srdan Verstovsek, MD PhD, Sa A Wang, MD, Joseph D. Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Richard E. Champlin, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, Heather M. Schroeder, Maria Khouri, Koichi Takahashi, MD PhD, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
DOI: https://doi.org/10.1182/blood-2020-142121
Published: 2020
Journal Articles

A Randomized Study of Pretransplant Conditioning Therapy for AML/MDS with Fludarabine ± Clofarabine and Once Daily IV Busulfan with Allogeneic Hematopoietic Transplantation for AML and MDS

Borje S. Andersson, MD, PhD, Peter Thall, Benigno C. Valdez, PhD, Junsheng Ma, MS, Julianne Chen, Sairah Ahmed, MD, Amin M. Alousi, MD, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Alison Gulbis, Chitra Hosing, MD, Roy B. Jones, MD PhD, Jitesh Kawedia, BPharm, Partow Kebriaei, MD, Steven M. Kornblau, MD, Alan Myers, PharmD, PhD RPh, Betul Oran, MDMS, Katayoun Rezvani, MD PhD, Nina Shah, MD, Elizabeth J. Shpall, MD, Simrit Parmar, MD, MSCI, Uday R. Popat, MD, Yago Nieto, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
DOI: https://doi.org/10.1182/blood-2020-142680
Published: 2020
Journal Articles

Haploidentical Mbil-21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Multiple Relapsed and Refractory Acute Myeloid Leukemia

Stefan O. Ciurea, MD, Jolie Schafer, Piyanuch Kongtim, MD, Julianne Chen, Doris Soebbing, Kai Cao, MS, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Marina Konopleva, MD PhD, Dean Anthony Lee, MD PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
DOI: https://doi.org/10.1182/blood-2020-134858
Published: 2020
Journal Articles

Lower Risk of Graft Versus Host Disease after Exposure to Checkpoint Inhibitors with the Use of Post-Transplant Cyclophosphamide Prophylaxis

Chantal Saberian, MD, Noha Abdel-Wahab, Ala Abudayyeh, MD, Hind Rafei, MD, Jacinth Joseph, MD, May Daher, Stephen K. Gruschkus, PhD MPH, Cristina Knape, Laura Whited, Alison Gulbis, Megan Marcotulli, Gabriela Rondon, Uday R. Popat, MD, Rohtesh S. Mehta, MDMPH,MS, Marina Konopleva, MD PhD, Betul Oran, MDMS, Maro Ohanian, DO, Farhad Ravandi, MBBS, Guillermo Garcia-Manero, MD, Amin M. Alousi, MD, Naval Daver, MD, Richard E. Champlin, MD, Adi Diab, MD, Gheath Alatrash
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
DOI: https://doi.org/10.1182/blood-2020-139614
Published: 2020
Journal Articles

Maintenance Therapy with Ipilimumab Plus Lenalidomide after Autologous Stem Cell Transplantation for Patients with Lymphoma

Issa F. Khouri, MD, Denái R. Milton, MS, Celina Ledesma, Elias Jabbour, MD, Qaiser Bashir, Jin S. Im, Luis Fayad, Hun Ju Lee, MD, Ranjit Nair, Loretta J. Nastoupil, MD, Felipe Samaniego, MD, Swami P. Iyer, MD, Christopher Flowers, MDMS, Richard E. Champlin, MD, Padmanee Sharma, Alison Gulbis
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–11.
DOI: https://doi.org/10.1182/blood-2020-138778
Published: 2020
Journal Articles

Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft Versus Host Disease

Rohtesh S. Mehta, MDMPH,MS, Rima M. Saliba, PhD, Anna Jan, Terri Lynn Shigle, PharmD, Emily Wang, Gabriela Rondon, Yago Nieto, MD, Stefan Ciurea, MD, Betul Oran, MDMS, Jin S. Im, Amanda L. Olson, David Marin, Muzaffar H. Qazilbash, MD, Issa F. Khouri, MD, Paolo Anderlini, Katayoun Rezvani, MD PhD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Amin M. Alousi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
DOI: https://doi.org/10.1182/blood-2020-139283
Published: 2020
Journal Articles

Long-Term Survival for Myeloma after Autologous Stem Cell Transplantation

Samer A. Srour, MD MS, Qaiser Bashir, MD, Denái R. Milton, MS, Yago Nieto, MD, Rohtesh S. Mehta, MDMPH,MS, Neeraj Saini, MD, Ruby Delgado, Gabriela Rondon, Stefan O. Ciurea, MD, Uday R. Popat, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, Elisabet E. Manasanch, MD, Chitra Hosing, MD, Krina K. Patel, MD, Hans C. Lee, MD, Elizabeth J. Shpall, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
DOI: https://doi.org/10.1182/blood-2020-143053
Published: 2020
Journal Articles

Survival Trends in Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplantation

Samer A. Srour, MD MS, Qaiser Bashir, MD, Denái R. Milton, MS, Yago Nieto, MD, Rohtesh S. Mehta, MDMPH,MS, Neeraj Saini, MD, Ruby Delgado, Gabriela Rondon, Chitra Hosing, MD, Stefan O. Ciurea, MD, May Daher, Uday R. Popat, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, Elisabet E. Manasanch, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Elizabeth J. Shpall, MD, Hans C. Lee, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
DOI: https://doi.org/10.1182/blood-2020-143196
Published: 2020
Journal Articles

Minimal Residual Disease Eradication with Guadecitabine (SGI-110) in the Post-Transplant Setting

Betul Oran, MDMS, Amin M. Alousi, MD, Rohtesh S. Mehta, MDMPH,MS, David Marin, Partow Kebriaei, MD, Uday R. Popat, MD, Amanda L. Olson, Jessica M McCarty, RN, Jennifer D Ramos, RN, Roland Bassett, Harold N. Keer, MDPhD, Peter F Thall, PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
DOI: https://doi.org/10.1182/blood-2020-134204
Published: 2020
Journal Articles

Transplant Outcomes with Fludarabine and Melphalan in High Risk AML Patients By Donor Types

Betul Oran, MDMS, Stefan O. Ciurea, MD, Rohtesh S. Mehta, MDMPH,MS, Amin M. Alousi, MD, Gabriela Rondon, Uday R. Popat, MD, David Marin, May Daher, Jin S. Im, Partow Kebriaei, MD, Gheath Alatrash, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
DOI: https://doi.org/10.1182/blood-2020-134474
Published: 2020
Journal Articles

Outcomes of Patients with Multiple Myeloma Who Received VRD Induction, Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance

Mahmoud R. Gaballa, MD, Taha Al-Juhaishi, MD, Qaiser Bashir, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Yago Nieto, MD, Regan Murphy, PA-C, Hans C. Lee, MD, Krina K. Patel, MD, Partow Kebriaei, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
DOI: https://doi.org/10.1182/blood-2020-135865
Published: 2020
Journal Articles

Prognostic Impact of Beta 2 Microglobulin in Patients with Immunoglobulin Light-Chain Amyloidosis Undergoing Autologous Hematopoietic Stem Cell Transplantation

Aimaz Afrough, MD, Samer A. Srour, MD MS, Qaiser Bashir, MD, Neeraj Saini, MD, Chitra Hosing, MD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Ruby Delgado, Regan Murphy, PA-C, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
DOI: https://doi.org/10.1182/blood-2020-141360
Published: 2020
Journal Articles

Retrospective Review of Prognostic and Predictors Markers in Newly Diagnosed Angioimmunoblastic T Cell Lymphoma at UT MD Anderson Cancer Center

Samer A. Srour, MD MS, Jie Xu, MD, Taha Al-Juhaishi, MD, Raphael Eric Steiner, MD, Joe Ensor, PhD, Sairah Ahmed, MD, Simrit Parmar, MD, MSCI, Paolo Strati, MD, Loretta J. Nastoupil, MD, Yago Nieto, MD, Chitra Hosing, MD, Hun Ju Lee, MD, Jason Westin, MD, Nathan H. Fowler, MD, Luis Fayad, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Penny Fang, MD, Felipe Samaniego, MD, Preetesh Jain, MBBS,MDDM,PhD, Richard E. Champlin, MD, Issa F. Khouri, MD, Michael Wang, MD, Roberto N. Miranda, MD, Francisco Vega, MDPhD, Sattva S. Neelapu, MD, Christopher Flowers, MDMS, Swami P. Iyer, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
DOI: https://doi.org/10.1182/blood-2020-143228
Published: 2020